Challenging the Prognostic Role of NLR in SCLC in the Era of Immunotherapy
Final PICCOLO Data Highlight Efficacy of Mirvetuximab Soravtansine in Later-Line Frα+ Platinum-Sensitive Ovarian Cancer
AJMC® in the Press, June 27, 2025
Differentially Expressed Genes May Serve as IPF Biomarkers
The Role of Real-World Data in Advancing Value-Based Cancer Care: CK Wang, MD
Post-Hoc Analysis Evaluates Ruxolitinib Plus Anemia-Supportive Therapies in Myelofibrosis: Pankit Vachhani, MD
Deep Learning Biomarkers Help Uncover ENV-101 Treatment Effects in IPF
Liso-Cel Improves Outcomes in R/R CLL/SLL Following 2 or More Lines of Therapy
INCA33989 Shows Disease-Modifying Potential With Favorable Safety in Essential Thrombocythemia: John Mascarenhas, MD
Protecting Progress in LGBTQ+ Health Care 10 Years After Obergefell
SCOTUS Rules Abortion Clinics Can Not Challenge South Carolina’s Medicaid Order
Marstacimab Improved Key Bleeding Outcomes in Hemophilia A or B
Phase 1 Trials Assess Safety, Dosing of CAL-R Antibody for Essential Thrombocythemia: John Mascarenhas, MD
Self-Administered Subcutaneous Isatuximab May Ease Multiple Myeloma Treatment Burden: Xavier Leleu, MD, PhD
Mitotic Rate, Lymphovascular Invasion Among Risk Factors for Relapse in Melanoma
Pharmacists Expand Frontline Role in US Hospitals, Survey Finds
Camlipixant May Benefit Patients With High-Burden RCC
iAMD Progression Linked to Dysregulation of Complement Pathways
Increasing Biosimilar Use Reflects Changing Practice in Pediatric IBD Care
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD
CDC Vaccine Panel Meets for First Time After RFK Jr Expelled Former Members
Trial Supports Subcutaneous Isatuximab as Effective Alternative to IV Version: Xavier Leleu, MD, PhD
Quality of Life Disparities Persist in R/R Multiple Myeloma Despite Universal Health Care: Francesco Sparano, MSc
First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer
Reducing Oral Corticosteroid Dependence in Severe Asthma by Balancing Benefits, Burdens, Path to Safer Care
Long-Term Data Support Cilta-Cel Use in R/R Multiple Myeloma: Sundar Jagannath, MBBS
Atrasentan Has Promising Long-Term Potential in IgA Nephropathy: Richard Lafayette, MD, FACP
Patients With Obesity Face Higher Financial Burden, Food Insecurity
Falling Vaccination Rates May Bring Back Measles, Polio in US
In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel